IPO Watch: ActivBiotics Targets Bacterial Diseases/Inflammation

November 9, 2006 – ActivBiotics, based in Lexington, Mass., is an antibacterial company with two products in three separate clinical trials. With just 21 employees, ActiveBiotics adopted the modern model for an emerging biotech: its executives have extensive biotech experience, but products are in-licensed and most of the R&D operations are outsourced to other companies, keeping the fixed overhead costs low. We look at the company and its drug candidates...

MORE ON THIS TOPIC